Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 2
2013 1
2015 1
2016 1
2017 3
2018 2
2019 5
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response.
Boustani J, Grapin M, Laurent PA, Apetoh L, Mirjolet C. Boustani J, et al. Among authors: mirjolet c. Cancers (Basel). 2019 Jun 20;11(6):860. doi: 10.3390/cancers11060860. Cancers (Basel). 2019. PMID: 31226866 Free PMC article. Review.
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
Grapin M, Richard C, Limagne E, Boidot R, Morgand V, Bertaut A, Derangere V, Laurent PA, Thibaudin M, Fumet JD, Crehange G, Ghiringhelli F, Mirjolet C. Grapin M, et al. Among authors: mirjolet c. J Immunother Cancer. 2019 Jun 25;7(1):160. doi: 10.1186/s40425-019-0634-9. J Immunother Cancer. 2019. PMID: 31238970 Free PMC article.
Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.
Thibouw D, Truc G, Bertaut A, Chevalier C, Aubignac L, Mirjolet C. Thibouw D, et al. Among authors: mirjolet c. J Neurooncol. 2018 Apr;137(2):429-438. doi: 10.1007/s11060-017-2735-y. Epub 2018 Jan 27. J Neurooncol. 2018. PMID: 29374810
HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells.
Causse SZ, Marcion G, Chanteloup G, Uyanik B, Boudesco C, Grigorash BB, Douhard R, Dias AMM, Dumetier B, Dondaine L, Gozzi GJ, Moussay E, Paggetti J, Mirjolet C, de Thonel A, Dubrez L, Demidov ON, Gobbo J, Garrido C. Causse SZ, et al. Among authors: mirjolet c. Oncogene. 2019 Apr;38(15):2767-2777. doi: 10.1038/s41388-018-0616-2. Epub 2018 Dec 12. Oncogene. 2019. PMID: 30542121 Free article.
Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors.
Loiseau A, Boudon J, Oudot A, Moreau M, Boidot R, Chassagnon R, Saïd NM, Roux S, Mirjolet C, Millot N. Loiseau A, et al. Among authors: mirjolet c. Cancers (Basel). 2019 Dec 6;11(12):1962. doi: 10.3390/cancers11121962. Cancers (Basel). 2019. PMID: 31817706 Free PMC article.
Polydopamine Modified Superparamagnetic Iron Oxide Nanoparticles as Multifunctional Nanocarrier for Targeted Prostate Cancer Treatment.
Singh N, Sallem F, Mirjolet C, Nury T, Sahoo SK, Millot N, Kumar R. Singh N, et al. Among authors: mirjolet c. Nanomaterials (Basel). 2019 Jan 22;9(2):138. doi: 10.3390/nano9020138. Nanomaterials (Basel). 2019. PMID: 30678236 Free PMC article.
The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy.
Mirjolet C, Boidot R, Saliques S, Ghiringhelli F, Maingon P, Créhange G. Mirjolet C, et al. Cancer Treat Rev. 2015 Apr;41(4):354-60. doi: 10.1016/j.ctrv.2015.02.005. Epub 2015 Feb 11. Cancer Treat Rev. 2015. PMID: 25704912 Review.
Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.
Mirjolet C, Boudon J, Loiseau A, Chevrier S, Boidot R, Oudot A, Collin B, Martin E, Joy PA, Millot N, Créhange G. Mirjolet C, et al. Int J Nanomedicine. 2017 Aug 30;12:6357-6364. doi: 10.2147/IJN.S139167. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28919739 Free PMC article.
NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.
Wu Q, Allouch A, Paoletti A, Leteur C, Mirjolet C, Martins I, Voisin L, Law F, Dakhli H, Mintet E, Thoreau M, Muradova Z, Gauthier M, Caron O, Milliat F, Ojcius DM, Rosselli F, Solary E, Modjtahedi N, Deutsch E, Perfettini JL. Wu Q, et al. Among authors: mirjolet c. Cell Death Differ. 2017 Sep;24(9):1632-1644. doi: 10.1038/cdd.2017.91. Epub 2017 Jun 2. Cell Death Differ. 2017. PMID: 28574504 Free PMC article.
Taxane-Grafted Metal-Oxide Nanoparticles as a New Theranostic Tool against Cancer: The Promising Example of Docetaxel-Functionalized Titanate Nanotubes on Prostate Tumors.
Loiseau A, Boudon J, Mirjolet C, Créhange G, Millot N. Loiseau A, et al. Among authors: mirjolet c. Adv Healthc Mater. 2017 Aug;6(16). doi: 10.1002/adhm.201700245. Epub 2017 May 18. Adv Healthc Mater. 2017. PMID: 28516460
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback